CA
NZ
UK
AU
IND
US
Director David R. Brooks filed a Form 4 with the SEC on August 7, 2026, disclosing the sale of a combined 24,650 shares of SouthState Bank Corp (NYSE: SSB) common stock on August 5, 2026, across four indirectly held accounts.
Mitchell Gendel, Global General Counsel of Tilray Brands, Inc. (NASDAQ: TLRY), filed a Form 4 on August 7, 2026, disclosing a purchase of 2,500 shares of common stock on August 6, 2026.
Dean J. Nolden, Chief Financial Officer of Alliance Laundry Holdings Inc., filed a Form 4 on August 7, 2026, reporting the exercise of stock options and the subsequent sale of common shares on August 5, 2026.
Dustin Olson, Chief Executive Officer and Director of PureCycle Technologies, Inc., filed a statement of changes in beneficial ownership on August 7, 2026, reporting a transaction in the company's common stock dated August 5, 2026.
Michael Donald Schoeb, Chief Executive Officer and Director of Alliance Laundry Holdings Inc. (ALH), filed a Form 4 on August 7, 2026, disclosing the disposition of 83,286 shares of common stock on August 5, 2026.
Thomas F. Cherry, President and Chief Executive Officer of C & F Financial Corp, filed a statement of changes in beneficial ownership on August 7, 2026, disclosing the sale of 500 shares of common stock on August 5, 2026.
A Form 4 filed on August 7, 2026 reports that Timothy Archer, President and CEO of Lam Research Corp (NASDAQ: LRCX), exercised employee stock options and sold 30,000 shares of common stock on August 6, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.
A Form 4 filed with the SEC on August 7, 2026 disclosed that D. Anthony Peay, a director of C & F Financial Corp (NASDAQ: CFFI), sold 425 shares of common stock on August 5, 2026.
A Form 4 filed on August 7, 2026 discloses that Maggie Yuen, a director of AtriCure, Inc. (NASDAQ: ATRC), sold 3,500 shares of common stock on August 5, 2026 at a weighted average price of $38.42 per share.
A Form 4 filed with the SEC on August 7, 2026, discloses that Karen Prange, a director of AtriCure, Inc. (NASDAQ: ATRC), sold 3,564 shares of common stock on August 5, 2026.
Please wait processing your request...